EP240: Beyond Mold: Exploring the Continent of the Cell Danger Response - Part 2 - Andrew Heyman, MD, MHSA

🎧 Episode Summary

In this episode, Andrew Heyman, MD, MHSA, continues exploring complex chronic illness through the broader framework of the Cell Danger Response and his five-phase treatment model.

Building on Part 1, he examines Actinobacteria, endotoxins, MARCoNS, fungal colonization, detoxification, phospholipid replacement, hidden infections, the microbiome, and nervous system regulation as part of moving through CDR1.

The conversation then explores CDR2 and CDR3, including mitochondrial and metabolic restoration, immune regulation, safety signaling, VIP, and strategies for rebuilding resilience and supporting a return to health.

🧭 In This Episode

- Actinobacteria exposure and its role within the CIRS model

- Environmental and gut-derived endotoxins as drivers of inflammation

- Detoxification strategies for chemicals, pesticides, and heavy metals

- Phospholipid replacement for detoxification, cell membranes, and mitochondrial support

- RG3 (Synapsin) for neuroinflammation and microglial activation

- Pathogen reduction for Lyme disease, Candida, SIBO, parasites, and reactivated viruses

- MARCoNS and nasal dysbiosis in chronic inflammatory illness